Pharmaceutical Investing European CHMP Adopts Positive Opinion for Yescarta (axicabtagene ciloleucel)
Pharmaceutical Investing Alexion Submits Application for Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria in the EU
Pharmaceutical Investing Cascadian Therapeutics Gets Pediatric Investigation Plan Waiver for Lead Candidate
